CD44 and Miyoshi myopathy: The present data support AR42 regulation of cell proliferation genes resulting in enhanced tumor cell clearance when paired with various cytotoxic agents, such as pazopanib, cisplatin, or decitabine, and the sensitization of MM cells to lenalidomide through CD44 upregulation [20,21,23,27].